2,377 results on '"Haynes, Barton"'
Search Results
2. Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
3. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction
4. Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
5. Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
6. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques
7. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
8. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
9. Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
10. Human Immunodeficiency Virus Vaccines
11. Contributors
12. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
13. 116 Relative location of prime-boost immunization determines memory B cell fate
14. HIV-1 Vpu restricts Fc-mediated effector functions in vivo
15. SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition
16. Structural diversity of the SARS-CoV-2 Omicron spike
17. Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
18. Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy
19. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1
20. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
21. Expression of membrane Hsp90 is a molecular signature of T cell activation
22. Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
23. Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
24. The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
25. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge
26. Computational analysis of antibody dynamics identifies recent HIV-1 infection
27. Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination
28. A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals
29. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
30. Microsecond dynamics control the HIV-1 Envelope conformation
31. Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody
32. SARS-CoV-2 Omicron XBB Lineage Spike Structures, Conformations, Antigenicity, and Receptor Recognition
33. Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models
34. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
35. Contribution of proteasome-catalyzed peptide cis -splicing to viral targeting by CD8⁺ T cells in HIV-1 infection
36. Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
37. Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
38. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
39. Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
40. Cold sensitivity of the SARS-CoV-2 spike ectodomain
41. Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
42. Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies
43. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates
44. Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies
45. Controlling the SARS-CoV-2 spike glycoprotein conformation
46. HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
47. Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center
48. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
49. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
50. Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.